Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Serevent

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PurposeTo measure the charge to mass (Q/M) ratios of the impactor stage masses (ISM) from commercial Flixotide™ 250 μg Evohaler… Expand
  • figure 1
  • figure 2
  • table I
  • figure 3
  • table II
Is this relevant?
2009
2009
Asthma prevalence, morbidity, and mortality in the United States have increased during the past decade despite major national… Expand
Is this relevant?
2002
2002
AIM To compare clinical, device and biochemical aspects of monotherapy with flixotide vs combination of flixotide with serevent… Expand
Is this relevant?
1998
1998
BACKGROUND The United States Food and Drug Administration has changed its policy regarding product labeling of asthma MDIs. All… Expand
Is this relevant?
1996
1996
  • P. Panghea, G. Voicu, +4 authors D Mihai
  • Pneumoftiziologia : revista Societatii Romane de…
  • 1996
  • Corpus ID: 11141559
A group of 20 patients with moderate bronchial asthma aged 18 through 65, previously treated with Becotide inhaler for 4 weeks… Expand
Is this relevant?
1994
1994
: An open study to assess the efficacy and safety of 50 micrograms inhaled Salmeterol (Serevent) administered twice daily as… Expand
Is this relevant?
1994
1994
An open study to assess the efficacy and safety of 50 micrograms inhaled Salmeterol (Serevent) administered twice daily as… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
OBJECTIVE--To compare safety of salmeterol and salbutamol in treating asthma. DESIGN--Double blind, randomised clinical trial in… Expand
Is this relevant?
1993
1993
The study aimed at estimating the acting duration of salmeterol (Serevent, Glaxo), a long-term beta 2-agonist bronchodilator… Expand
Is this relevant?